Dupilumab for the treatment of pemphigoid gestationis in the setting of breastfeeding: a case report and review of the literature
Gabriela Soto-Canetti, Kristina Navrazhina, Jordan Talia · 2026
Read Dupilumab for the treatment of pemphigoid gestationis in the setting of breastfeeding: a case report and review of the literature by Gabriela Soto-Canetti, Kristina Navrazhina, Jordan Talia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424896.txt.
Description
Gabriela Soto-Canetti, Kristina Navrazhina, and Jordan Talia report using dupilumab to treat pemphigoid gestationis in a nursing mother who could not come off steroids. Pemphigoid gestationis is a rare blistering skin disease of pregnancy. Their patient, a 34-year-old woman at thirty-two weeks, developed badly itchy raised plaques and tense blisters across her trunk and limbs, confirmed by biopsy.
High-dose prednisone barely held the disease, and every attempt to taper over four weeks failed. After delivery the condition worsened and the steroid dose climbed again. Because she was breastfeeding, dupilumab, an antibody blocking the interleukin-4 receptor, was started as a steroid-sparing option, letting prednisone be withdrawn with major gains. A review of published cases comes with the report.
Catalog record
| CREATOR | Gabriela Soto-Canetti, Kristina Navrazhina, Jordan Talia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18873 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |